{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T11:52:18Z","timestamp":1718279538317},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":2056,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1194\/jlr.d052985","type":"journal-article","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T03:49:05Z","timestamp":1417578545000},"page":"470-483","source":"Crossref","is-referenced-by-count":5,"title":["Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis"],"prefix":"10.1016","volume":"56","author":[{"given":"Timothy J.","family":"Sontag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijoy","family":"Chellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa V.","family":"Bhanvadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godfrey S.","family":"Getz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine A.","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.D052985_bib1","first-page":"1","article-title":"Deaths: final data for 2006","volume":"57","author":"Heron","year":"2009","journal-title":"Natl. Vital Stat. Rep."},{"key":"10.1194\/jlr.D052985_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. the road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell."},{"key":"10.1194\/jlr.D052985_bib3","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1172\/JCI30163","article-title":"Molecular regulation of HDL metabolism and function: implications for novel therapies","volume":"116","author":"Rader","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.D052985_bib4","doi-asserted-by":"crossref","first-page":"19L","DOI":"10.1016\/S0002-9149(00)01464-8","article-title":"High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High\u2013Density Lipoprotein Intervention Trial","volume":"86","author":"Boden","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.D052985_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.ATV.8.6.737","article-title":"High density lipoprotein cholesterol and mortality. The Framingham Heart Study","volume":"8","author":"Wilson","year":"1988","journal-title":"Arteriosclerosis."},{"key":"10.1194\/jlr.D052985_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation."},{"key":"10.1194\/jlr.D052985_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.D052985_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2796.2007.01898.x","article-title":"Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins","volume":"263","author":"Tall","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1194\/jlr.D052985_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/ATVBAHA.113.302437","article-title":"Importance of evaluating cell cholesterol influx with efflux in determining the impact of human serum on cholesterol metabolism and atherosclerosis","volume":"34","author":"Weibel","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.D052985_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.CIR.0000086981.09834.E0","article-title":"Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation."},{"key":"10.1194\/jlr.D052985_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.12.044","article-title":"In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: new tools for predicting HDL atheroprotection","volume":"206","author":"Escol\u00e0-Gil","year":"2009","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.D052985_bib12","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1161\/ATVBAHA.112.300133","article-title":"High-density lipoprotein function, dysfunction, and reverse cholesterol transport","volume":"32","author":"Fisher","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.D052985_bib13","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI57275","article-title":"Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis","volume":"121","author":"Rayner","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.D052985_bib14","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/ATVBAHA.107.146068","article-title":"In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired","volume":"27","author":"Wang","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.D052985_bib15","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1172\/JCI32057","article-title":"Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.D052985_bib16","doi-asserted-by":"crossref","first-page":"283486","DOI":"10.1155\/2013\/283486","article-title":"The impairment of macrophage-to-feces reverse cholesterol transport during inflammation does not depend on serum amyloid A","volume":"2013","author":"de Beer","year":"2013","journal-title":"J. Lipids."},{"key":"10.1194\/jlr.D052985_bib17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cvr\/cvm087","article-title":"The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport","volume":"77","author":"Tchoua","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1194\/jlr.D052985_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/CIRCULATIONAHA.108.825109","article-title":"Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo","volume":"120","author":"Tanigawa","year":"2009","journal-title":"Circulation."},{"key":"10.1194\/jlr.D052985_bib19","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1161\/ATVBAHA.109.191379","article-title":"Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano","volume":"29","author":"Alexander","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.D052985_bib20","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2008.03.016","article-title":"Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches","volume":"51","author":"deGoma","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.D052985_bib21","doi-asserted-by":"crossref","first-page":"15641","DOI":"10.1074\/jbc.M010230200","article-title":"Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice","volume":"276","author":"Alam","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.D052985_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1172\/JCI200112473","article-title":"Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL","volume":"108","author":"Groen","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.D052985_bib23","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1073\/pnas.93.9.4114","article-title":"Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma","volume":"93","author":"Osono","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.D052985_bib24","doi-asserted-by":"crossref","first-page":"e001826","DOI":"10.1161\/JAHA.112.001826","article-title":"Measurement of reverse cholesterol transport pathways in humans: in vivo rates of free cholesterol efflux, esterification, and excretion","volume":"1","author":"Turner","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1194\/jlr.D052985_bib25","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.100.6.594","article-title":"Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans","volume":"100","author":"Eriksson","year":"1999","journal-title":"Circulation."},{"key":"10.1194\/jlr.D052985_bib26","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1194\/jlr.M008441","article-title":"Importance of macrophage cholesterol content on the flux of cholesterol mass","volume":"51","author":"Sankaranarayanan","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D052985_bib27","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1161\/ATVBAHA.111.236406","article-title":"Novel in vivo method for measuring cholesterol mass flux in peripheral macrophages","volume":"31","author":"Weibel","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.D052985_bib28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3891\/acta.chem.scand.20-1026","article-title":"The influence of pH on the rate of hydrolysis of acidic polysaccharides","volume":"20","author":"Smidsrod","year":"1966","journal-title":"Acta Chem. Scand."},{"key":"10.1194\/jlr.D052985_bib29","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1089\/ten.tea.2009.0286","article-title":"In vivo selection of biocompatible alginates for islet encapsulation and subcutaneous transplantation","volume":"16","author":"V\u00e9riter","year":"2010","journal-title":"Tissue Eng. Part A."},{"key":"10.1194\/jlr.D052985_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1073\/pnas.76.1.333","article-title":"Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition","volume":"76","author":"Goldstein","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.D052985_bib31","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1194\/jlr.M700552-JLR200","article-title":"Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties","volume":"49","author":"Wool","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D052985_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1194\/jlr.M044305","article-title":"IL-22 is induced by S100\/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1","volume":"55","author":"Chellan","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D052985_bib33","article-title":"Bone marrow-derived macrophages (BMM): isolation and applications","volume":"2008","author":"Weischenfeldt","year":"2008","journal-title":"CSH Protoc."},{"key":"10.1194\/jlr.D052985_bib34","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0022-2275(20)37926-8","article-title":"Isolation and characterization of lipoprotein of density less than 1.006 g\/ml from rat hepatic lymph","volume":"24","author":"Tso","year":"1983","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D052985_bib35","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1194\/jlr.D007336","article-title":"A simple and sensitive enzymatic method for cholesterol quantification in macrophages and foam cells","volume":"51","author":"Robinet","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D052985_bib36","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/0141-0229(93)90167-Z","article-title":"Characterization of calcium alginate pore diameter by size-exclusion chromatography using protein standards","volume":"15","author":"Stewart","year":"1993","journal-title":"Enzyme Microb. Technol."},{"key":"10.1194\/jlr.D052985_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/(SICI)1097-0290(19960520)50:4<365::AID-BIT3>3.0.CO;2-J","article-title":"Transport characterization of hydrogel matrices for cell encapsulation","volume":"50","author":"Li","year":"1996","journal-title":"Biotechnol. Bioeng."},{"key":"10.1194\/jlr.D052985_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-3155-9-24","article-title":"Determination of pore size distribution at the cell-hydrogel interface","volume":"9","author":"Leal-Ega\u00f1a","year":"2011","journal-title":"J. Nanobiotechnology."},{"key":"10.1194\/jlr.D052985_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1476-511X-10-181","article-title":"High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study","volume":"10","author":"Wojczynski","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1194\/jlr.D052985_bib40","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0022-2275(20)37227-8","article-title":"ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes","volume":"38","author":"Plump","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D052985_bib41","doi-asserted-by":"crossref","first-page":"26565","DOI":"10.1074\/jbc.M203014200","article-title":"Apolipoprotein A-I is necessary for the in vivo formation of high density lipoprotein competent for scavenger receptor BI-mediated cholesteryl ester-selective uptake","volume":"277","author":"Temel","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.D052985_bib42","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.RES.0000185320.82962.F7","article-title":"Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation","volume":"97","author":"Moore","year":"2005","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.D052985_bib43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science."},{"key":"10.1194\/jlr.D052985_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.ATV.14.1.141","article-title":"Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression","volume":"14","author":"Reddick","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1194\/jlr.D052985_bib45","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-2275(20)33505-7","article-title":"Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma","volume":"40","author":"Whitman","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D052985_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9150(00)00457-3","article-title":"The LDL receptor is the major pathway for beta-VLDL uptake by mouse peritoneal macrophages","volume":"154","author":"Perrey","year":"2001","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.D052985_bib47","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.D052985_bib48","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1096\/fj.01-0463com","article-title":"Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans","volume":"15","author":"Moghadasian","year":"2001","journal-title":"FASEB J."},{"key":"10.1194\/jlr.D052985_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1476-511X-12-112","article-title":"Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9","volume":"12","author":"Choi","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1194\/jlr.D052985_bib50","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/me.2003-0061","article-title":"Liver X receptor signaling pathways in cardiovascular disease","volume":"17","author":"Tontonoz","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1194\/jlr.D052985_bib51","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1016\/0002-9343(92)90294-L","article-title":"Novel drug-delivery systems for hypertension","volume":"93","author":"Prisant","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1194\/jlr.D052985_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-3659(01)00379-0","article-title":"Investigation on a novel core-coated microspheres protein delivery system","volume":"75","author":"Zhou","year":"2001","journal-title":"J. Control. Release."},{"key":"10.1194\/jlr.D052985_bib53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nm0103-104","article-title":"Cell encapsulation: promise and progress","volume":"9","author":"Orive","year":"2003","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.D052985_bib54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0022-2275(20)39912-0","article-title":"Effect of apolipoprotein A-I deficiency on lecithin:cholesterol acyltransferase activation in mouse plasma","volume":"36","author":"Parks","year":"1995","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.D052985_bib55","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1194\/jlr.M013235","article-title":"ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis","volume":"52","author":"Wang","year":"2011","journal-title":"J. Lipid Res."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520356315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520356315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.D052985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T19:19:38Z","timestamp":1637435978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520356315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0022227520356315"],"URL":"https:\/\/doi.org\/10.1194\/jlr.d052985","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}